Progyny [PGNY] vs Cigna [CI] Detailed Stock Comparison

Progyny Inc.

NASDAQ
Loading...

The Cigna Group

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Progyny Inc. wins in 7 metrics, The Cigna Group wins in 12 metrics, with 0 ties. The Cigna Group appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Progyny Inc. The Cigna Group Better
P/E Ratio (TTM) 27.18 12.61 The Cigna Group
Price-to-Book Ratio 2.83 1.77 The Cigna Group
Debt-to-Equity Ratio 5.37 75.14 Progyny Inc.
PEG Ratio 1.09 -1.32 Progyny Inc.
EV/EBITDA 11.90 8.02 The Cigna Group
Profit Margin (TTM) 4.54% 2.17% Progyny Inc.
Operating Margin (TTM) 7.20% 3.53% Progyny Inc.
EBITDA Margin (TTM) 7.20% 3.53% Progyny Inc.
Return on Equity 12.48% 15.13% The Cigna Group
Return on Assets (TTM) 8.61% 4.09% Progyny Inc.
Free Cash Flow (TTM) $191.78M $8.39B The Cigna Group
Dividend Yield N/A 2.24% N/A
1-Year Return 26.63% -6.11% Progyny Inc.
Price-to-Sales Ratio (TTM) 1.12 0.27 The Cigna Group
Enterprise Value $1.16B $96.61B The Cigna Group
EV/Revenue Ratio 0.90 0.35 The Cigna Group
Gross Profit Margin (TTM) 24.15% N/A N/A
Revenue per Share (TTM) $15 $1,031 The Cigna Group
Earnings per Share (Diluted) $0.65 $22.18 The Cigna Group
Beta (Stock Volatility) 0.99 0.27 The Cigna Group
Short % of Float 10.89% 2.88% The Cigna Group

Progyny Inc. vs The Cigna Group Stock Performance Analysis

Loading Price Chart...

PGNY
CI

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Progyny Inc.1.05%3.82%15.74%54.48%2.16%4.55%
The Cigna Group-1.40%1.46%3.00%9.50%6.02%5.27%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Progyny Inc.26.63%-31.61%-58.69%67.06%67.06%67.06%
The Cigna Group-6.11%10.85%28.46%130.12%509.53%856.66%

Performance & Financial Health Analysis: Progyny Inc. vs The Cigna Group

MetricPGNYCI
Market Information
Market Cap i$1.45B$72.68B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,317,2181,414,431
90 Day Avg. Volume i1,312,3261,580,340
Last Close$26.91$293.83
52 Week Range$16.10 - $28.75$239.51 - $338.89
% from 52W High-6.40%-13.30%
All-Time High$68.32 (Nov 01, 2021)$370.83 (Sep 16, 2024)
% from All-Time High-60.61%-20.76%
Growth Metrics
Quarterly Revenue Growth0.07%0.10%
Quarterly Earnings Growth0.19%-0.13%
Financial Health
Profit Margin (TTM) i0.05%0.02%
Operating Margin (TTM) i0.07%0.04%
Return on Equity (TTM) i0.12%0.15%
Debt to Equity (MRQ) i5.3775.14
Cash & Liquidity
Book Value per Share (MRQ)$6.24$158.33
Cash per Share (MRQ)$3.79$33.14
Operating Cash Flow (TTM) i$210.19M$9.60B
Levered Free Cash Flow (TTM) i$212.50M$9.77B
Dividends
Last 12-Month Dividend Yield iN/A2.24%
Last 12-Month Dividend iN/A$6.09

Valuation & Enterprise Metrics Analysis: Progyny Inc. vs The Cigna Group

MetricPGNY (Apr 24, 2026)CI (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i27.1812.61
Forward P/E i8.418.37
PEG Ratio i1.09-1.32
Price to Sales (TTM) i1.120.27
Price to Book (MRQ) i2.831.77
Market Capitalization
Market Capitalization i$1.45B$72.68B
Enterprise Value i$1.16B$96.61B
Enterprise Value Metrics
Enterprise to Revenue i0.900.35
Enterprise to EBITDA i11.908.02
Risk & Other Metrics
Beta i0.990.27
Book Value per Share (MRQ) i$6.24$158.33

Financial Statements Comparison: Progyny Inc. vs The Cigna Group

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPGNY (2025)CI (2025)
Revenue/Sales i1.29B274.88B
Cost of Goods Sold i984.18MN/A
COGS % of Revenue i76.4%0.0%
Gross Profit i304.48MN/A
Gross Margin i23.6%0.0%
Research & Development iN/AN/A
Operating Income (EBIT) i85.28MN/A
Operating Margin i6.6%0.0%
EBITDA i90.23MN/A
EBITDA Margin i7.0%0.0%
Pre-Tax Income i95.43M7.78B
Pre-Tax Income % of Revenue i7.4%2.8%
Income Tax i36.91M1.49B
Income Tax % of Revenue i2.9%0.5%
Net Income (Profit) i58.52M6.29B
Profit Margin i4.5%2.3%

Balance Sheet & Liquidity Metrics

MetricPGNY (2025)CI (2025)
Cash & Equivalents i112.24M7.68B
Total Current Assets i551.78MN/A
Total Current Assets % of Revenue i42.8%0.0%
Total Current Liabilities i202.39MN/A
Total Current Liabilities % of Revenue i15.7%0.0%
Long-Term Debt i24.00M30.87B
Long-Term Debt % of Revenue i1.9%11.2%
Total Shareholders Equity i516.04M41.87B
Retained Earnings i202.83M47.87B
Retained Earnings % of Revenue i15.7%17.4%
Property, Plant & Equipment i24.99MN/A

Cash Flow Statement Comparison

MetricPGNY (2025)CI (2025)
Operating Cash Flow i201.98M5.57B
Operating Cash Flow % of Revenue i15.7%2.0%
Capital Expenditures i-18.41M-1.21B
Free Cash Flow i191.78M8.39B
FCF Margin i14.9%3.1%
Debt Repayment iN/A-6.20B
Common Stock Repurchase i-81.66M-3.62B

Short Interest & Institutional Ownership Analysis

MetricPGNYCI
Shares Short i6.08M6.80M
Short Ratio i3.783.61
Short % of Float i10.89%2.88%
Shares Outstanding i83.37M263.46M
Float Shares i74.96M262.25M
% Held by Insiders i1.91%1.44%
% Held by Institutions i114.23%92.21%
% Held by Public i-16.14%6.35%

Dividend Analysis & Yield Comparison: Progyny Inc. vs The Cigna Group

MetricPGNYCI
Last 12-Month Dividend iN/A$6.09
Last 12-Month Dividend Yield iN/A2.24%
3-Year Avg Annual Dividend iN/A$5.63
3-Year Avg Dividend Yield iN/A0.47%
3-Year Total Dividends iN/A$16.89
Ex-Dividend DateN/AMar 05, 2026